United States Hemodynamic Flow Alteration Devices Market Report 2021

◆商品コード:QYR60932137
◆発行会社(調査会社):QYResearch
◆発行日:2016年8月10日
◆ページ数:107
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:アメリカ
◆産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single UserUSD3,800 ⇒換算¥418,000見積依頼/購入/質問フォーム
Enterprise(全社内共有可)USD4,940 ⇒換算¥543,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Notes:_x000D_Sales, means the sales volume of Hemodynamic Flow Alteration Devices_x000D_
Revenue, means the sales value of Hemodynamic Flow Alteration Devices_x000D_
_x000D_
This report studies sales (consumption) of Hemodynamic Flow Alteration Devices in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering_x000D_
Boston Scientific Corporation_x000D_
Cardiovascular Systems_x000D_
Medtronic_x000D_
Spectranetics_x000D_
Abbott Laboratories_x000D_
B. Braun Melsungen AG_x000D_
C.R. Bard_x000D_
Cordis Corporation (A Subsidiary of Johnson & Johnson Co.)_x000D_
St. Jude Medical, Inc_x000D_
Medtronic, Inc._x000D_
Spectranetics International BV_x000D_
Terumo Corporation_x000D_
Volcano Corporation_x000D_
_x000D_
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into_x000D_
Embolic Protection Devices_x000D_
Type II_x000D_
Type III_x000D_
Split by applications, this report focuses on sales, market share and growth rate of Hemodynamic Flow Alteration Devices in each application, can be divided into_x000D_
Hospital_x000D_
Application 2_x000D_
Application 3_x000D_
_x000D_

【レポートの目次】

Table of Contents_x000D_
_x000D_
United States Hemodynamic Flow Alteration Devices Market Report 2021_x000D_
1 Hemodynamic Flow Alteration Devices Overview_x000D_
1.1 Product Overview and Scope of Hemodynamic Flow Alteration Devices_x000D_
1.2 Classification of Hemodynamic Flow Alteration Devices_x000D_
1.2.1 Embolic Protection Devices_x000D_
1.2.2 Type II_x000D_
1.2.3 Type III_x000D_
1.3 Applications of Hemodynamic Flow Alteration Devices_x000D_
1.3.1 Hospital_x000D_
1.3.2 Application 2_x000D_
1.3.3 Application 3_x000D_
1.4 USA Market Size (Value and Volume) of Hemodynamic Flow Alteration Devices (2011-2021)_x000D_
1.4.1 USA Hemodynamic Flow Alteration Devices Sales, Revenue and Price (2011-2021)_x000D_
1.4.2 USA Hemodynamic Flow Alteration Devices Sales and Growth Rate (2011-2021)_x000D_
1.4.3 USA Hemodynamic Flow Alteration Devices Revenue and Growth Rate (2011-2021)_x000D_
_x000D_
2 USA Hemodynamic Flow Alteration Devices Competition by Manufacturers_x000D_
2.1 USA Hemodynamic Flow Alteration Devices Sales and Market Share of Key Manufacturers (2015 and 2016)_x000D_
2.2 USA Hemodynamic Flow Alteration Devices Revenue and Share by Manufactures (2015 and 2016)_x000D_
_x000D_
3 USA Hemodynamic Flow Alteration Devices (Volume and Value) by Type_x000D_
3.1 USA Hemodynamic Flow Alteration Devices Sales and Market Share by Type (2011-2021)_x000D_
3.2 USA Hemodynamic Flow Alteration Devices Revenue and Market Share by Type (2011-2021)_x000D_
_x000D_
4 USA Hemodynamic Flow Alteration Devices (Volume) by Application_x000D_
_x000D_
5 USA Hemodynamic Flow Alteration Devices Manufacturers Analysis_x000D_
5.1 Boston Scientific Corporation_x000D_
5.1.1 Company Basic Information, Manufacturing Base and Competitors_x000D_
5.1.2 Hemodynamic Flow Alteration Devices Product Type and Technology_x000D_
5.1.2.1 Embolic Protection Devices_x000D_
5.1.2.2 Type II_x000D_
5.1.3 Hemodynamic Flow Alteration Devices Sales, Revenue, Price of Boston Scientific Corporation (2015 and 2016)_x000D_
5.2 Cardiovascular Systems_x000D_
5.2.1 Company Basic Information,Manufacturing Base and Competitors_x000D_
5.2.2 Medical Devices Product Type and Technology_x000D_
5.2.2.1 Embolic Protection Devices_x000D_
5.2.2.2 Type II_x000D_
5.2.3 Medical Devices Sales, Revenue, Price of Cardiovascular Systems (2015 and 2016)_x000D_
5.3 Medtronic_x000D_
5.3.1 Company Basic Information,Manufacturing Base and Competitors_x000D_
5.3.2 Medtronic Product Type and Technology_x000D_
5.3.2.1 Embolic Protection Devices_x000D_
5.3.2.2 Type II_x000D_
5.3.3 Medtronic Sales, Revenue, Price of Medtronic (2015 and 2016)_x000D_
5.4 Spectranetics_x000D_
5.4.1 Company Basic Information,Manufacturing Base and Competitors_x000D_
5.4.2 St. Jude Medical, Inc Product Type and Technology_x000D_
5.4.2.1 Embolic Protection Devices_x000D_
5.4.2.2 Type II_x000D_
5.4.3 Spectranetics Sales, Revenue, Price of Spectranetics (2015 and 2016)_x000D_
5.5 Abbott Laboratories_x000D_
5.5.1 Company Basic Information,Manufacturing Base and Competitors_x000D_
5.5.2 Abbott Laboratories Product Type and Technology_x000D_
5.5.2.1 Embolic Protection Devices_x000D_
5.5.2.2 Type II_x000D_
5.5.3 Abbott Laboratories Sales, Revenue, Price of Abbott Laboratories (2015 and 2016)_x000D_
5.6 B. Braun Melsungen AG_x000D_
5.6.1 Company Basic Information,Manufacturing Base and Competitors_x000D_
5.6.2 B. Braun Melsungen AG Product Type and Technology_x000D_
5.6.2.1 Embolic Protection Devices_x000D_
5.6.2.2 Type II_x000D_
5.6.3 B. Braun Melsungen AG Sales, Revenue, Price of B. Braun Melsungen AG (2015 and 2016)_x000D_
5.7 C.R. Bard_x000D_
5.7.1 Company Basic Information,Manufacturing Base and Competitors_x000D_
5.7.2 C.R. Bard Product Type and Technology_x000D_
5.7.2.1 Embolic Protection Devices_x000D_
5.7.2.2 Type II_x000D_
5.7.3 C.R. Bard Sales, Revenue, Price of C.R. Bard (2015 and 2016)_x000D_
5.8 Cordis Corporation (A Subsidiary of Johnson & Johnson Co.)_x000D_
5.8.1 Company Basic Information,Manufacturing Base and Competitors_x000D_
5.8.2 Cordis Corporation (A Subsidiary of Johnson & Johnson Co.) Product Type and Technology_x000D_
5.8.2.1 Embolic Protection Devices_x000D_
5.8.2.2 Type II_x000D_
5.8.3 Cordis Corporation (A Subsidiary of Johnson & Johnson Co.) Sales, Revenue, Price of Cordis Corporation (A Subsidiary of Johnson & Johnson Co.) (2015 and 2016)_x000D_
5.9 St. Jude Medical, Inc_x000D_
5.9.1 Company Basic Information,Manufacturing Base and Competitors_x000D_
5.9.2 St. Jude Medical, Inc Product Type and Technology_x000D_
5.9.2.1 Embolic Protection Devices_x000D_
5.9.2.2 Type II_x000D_
5.9.3 St. Jude Medical, Inc Sales, Revenue, Price of St. Jude Medical, Inc (2015 and 2016)_x000D_
5.10 Medtronic, Inc._x000D_
5.10.1 Company Basic Information,Manufacturing Base and Competitors_x000D_
5.10.2 Medtronic, Inc. Product Type and Technology_x000D_
5.10.2.1 Embolic Protection Devices_x000D_
5.10.2.2 Type II_x000D_
5.10.3 Medtronic, Inc. Sales, Revenue, Price of Medtronic, Inc. (2015 and 2016)_x000D_
5.11 Spectranetics International BV_x000D_
5.12 Terumo Corporation_x000D_
5.13 Volcano Corporation_x000D_
_x000D_
6 Hemodynamic Flow Alteration Devices Technology and Development Trend_x000D_
6.1 Hemodynamic Flow Alteration Devices Technology Analysis_x000D_
6.2 Hemodynamic Flow Alteration Devices Technology Development Trend_x000D_
_x000D_
7 Research Findings and Conclusion_x000D_
_x000D_
_x000D_

List of Tables and Figures _x000D_
_x000D_
Figure Picture of Hemodynamic Flow Alteration Devices_x000D_
Table Classification of Hemodynamic Flow Alteration Devices_x000D_
Figure USA Sales Market Share of Hemodynamic Flow Alteration Devices by Type in 2015_x000D_
Figure Embolic Protection Devices Picture_x000D_
Table Applications of Hemodynamic Flow Alteration Devices_x000D_
Figure USA Sales Market Share of Hemodynamic Flow Alteration Devices by Application in 2015_x000D_
Figure Hospital Examples_x000D_
Table USA Hemodynamic Flow Alteration Devices Sales, Revenue and Price (2011-2021)_x000D_
Figure USA Hemodynamic Flow Alteration Devices Sales and Growth Rate (2011-2021)_x000D_
Figure USA Hemodynamic Flow Alteration Devices Revenue and Growth Rate (2011-2021)_x000D_
Table USA Hemodynamic Flow Alteration Devices Sales of Key Manufacturers (2015 and 2016)_x000D_
Table USA Hemodynamic Flow Alteration Devices Sales Share by Manufacturers (2015 and 2016)_x000D_
Figure 2015 Hemodynamic Flow Alteration Devices Sales Share by Manufacturers_x000D_
Figure 2016 Hemodynamic Flow Alteration Devices Sales Share by Manufacturers_x000D_
Table USA Hemodynamic Flow Alteration Devices Revenue by Manufacturers (2015 and 2016)_x000D_
Table USA Hemodynamic Flow Alteration Devices Revenue Share by Manufacturers (2015 and 2016)_x000D_
Table 2015 USA Hemodynamic Flow Alteration Devices Revenue Share by Manufacturers_x000D_
Table 2016 USA Hemodynamic Flow Alteration Devices Revenue Share by Manufacturers_x000D_
Table USA Hemodynamic Flow Alteration Devices Sales and Market Share by Type (2011-2021)_x000D_
Table USA Hemodynamic Flow Alteration Devices Sales Share by Type (2011-2021)_x000D_
Figure Sales Market Share of Hemodynamic Flow Alteration Devices by Type (2011-2021)_x000D_
Figure USA Hemodynamic Flow Alteration Devices Sales Growth Rate by Type (2011-2021)_x000D_
Table USA Hemodynamic Flow Alteration Devices Revenue and Market Share by Type (2011-2021)_x000D_
Table USA Hemodynamic Flow Alteration Devices Revenue Share by Type (2011-2021)_x000D_
Figure Revenue Market Share of Hemodynamic Flow Alteration Devices by Type (2011-2021)_x000D_
Figure USA Hemodynamic Flow Alteration Devices Revenue Growth Rate by Type (2011-2021)_x000D_
Table USA Hemodynamic Flow Alteration Devices Sales and Market Share by Application (2011-2021)_x000D_
Table USA Hemodynamic Flow Alteration Devices Sales Share by Application (2011-2021)_x000D_
Figure Sales Market Share of Hemodynamic Flow Alteration Devices by Application (2011-2021)_x000D_
Figure USA Hemodynamic Flow Alteration Devices Sales Growth Rate by Application (2011-2021)_x000D_
Table Boston Scientific Corporation Basic Information List_x000D_
Table Hemodynamic Flow Alteration Devices Sales, Revenue, Price of Boston Scientific Corporation (2015 and 2016)_x000D_
Table Cardiovascular Systems Basic Information List_x000D_
Table Hemodynamic Flow Alteration Devices Sales, Revenue, Price of Cardiovascular Systems (2015 and 2016)_x000D_
Table Medtronic Basic Information List_x000D_
Table Hemodynamic Flow Alteration Devices Sales, Revenue, Price of Medtronic (2015 and 2016)_x000D_
Table Spectranetics Basic Information List_x000D_
Table Hemodynamic Flow Alteration Devices Sales, Revenue, Price of Spectranetics (2015 and 2016)_x000D_
Table Abbott Laboratories Basic Information List_x000D_
Table Hemodynamic Flow Alteration Devices Sales, Revenue, Price of Abbott Laboratories (2015 and 2016)_x000D_
Table B. Braun Melsungen AG Basic Information List_x000D_
Table Hemodynamic Flow Alteration Devices Sales, Revenue, Price of B. Braun Melsungen AG (2015 and 2016)_x000D_
Table C.R. Bard Basic Information List_x000D_
Table Hemodynamic Flow Alteration Devices Sales, Revenue, Price of C.R. Bard (2015 and 2016)_x000D_
Table Cordis Corporation (A Subsidiary of Johnson & Johnson Co.) Basic Information List_x000D_
Table Hemodynamic Flow Alteration Devices Sales, Revenue, Price of Cordis Corporation (A Subsidiary of Johnson & Johnson Co.) (2015 and 2016)_x000D_
Table St. Jude Medical, Inc Basic Information List_x000D_
Table Hemodynamic Flow Alteration Devices Sales, Revenue, Price of St. Jude Medical, Inc (2015 and 2016)_x000D_
Table Medtronic, Inc. Basic Information List_x000D_
Table Hemodynamic Flow Alteration Devices Sales, Revenue, Price of Medtronic, Inc. (2015 and 2016)_x000D_
Table Spectranetics International BV Basic Information List_x000D_
Table Hemodynamic Flow Alteration Devices Sales, Revenue, Price of Spectranetics International BV (2015 and 2016)_x000D_
Table Terumo Corporation Basic Information List_x000D_
Table Hemodynamic Flow Alteration Devices Sales, Revenue, Price of Terumo Corporation (2015 and 2016)_x000D_
Table Volcano Corporation Basic Information List_x000D_
Table Hemodynamic Flow Alteration Devices Sales, Revenue, Price of Volcano Corporation (2015 and 2016)_x000D_


★調査レポート[United States Hemodynamic Flow Alteration Devices Market Report 2021] (コード:QYR60932137)販売に関する免責事項を必ずご確認ください。
★調査レポート[United States Hemodynamic Flow Alteration Devices Market Report 2021]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆